Psy167 - Comparison of Pharmacoeconomic (Pe) Evaluations for Drugs for Rare Diseases (Drds) Evaluated by Cadth and Nice.

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2741
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Government Insists NHS Pays for Drugs Approved by NICE

BMJ
2001English

Pms83 - Comparison of French and German Hta Assessments for Three Recently Evaluated Rheumatoid Arthritis Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

New Drugs for Mental Diseases?: New Diseases for Old Drugs?

Journal of the Royal Society of Medicine
Medicine
1987English

The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases

Medical Decision Making
Health Policy
2014English

Comparison of Recent Hta Appraisals of Orphan Drugs by Nice, SMC and Has in 2015-2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN Guidelines

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Factors Associated With Positive and Negative Recommendations for Cancer and Non-Cancer Drugs for Rare Diseases in Canada

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2020English

PUK2 Issues in the Systematic Review of Drugs for Rare Diseases: A Case Study of Eculizumab for aHUS

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy